Statements (69)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:radar_system
|
| gptkbp:associated_with |
increased severity of disease
|
| gptkbp:clinical_trial |
ongoing for new vaccines
|
| gptkbp:collaboration |
international research efforts
|
| gptkbp:community_health |
increased testing and contact tracing
significant during waves of infection |
| gptkbp:community_transmission |
evident in various regions
|
| gptkbp:data_usage |
higher than original strain
|
| gptkbp:descendant |
gptkb:B.1.1.7
|
| gptkbp:discovered_by |
gptkb:United_Kingdom
|
| gptkbp:epidemiology |
conducted to assess spread
|
| gptkbp:genetic_changes |
multiple mutations in spike protein
|
| gptkbp:genetic_studies |
gptkb:N501_Y
P681 H A570 D D1118 H D614 G S982 A T716 I |
| gptkbp:genomic_data |
shared among researchers
|
| gptkbp:has_limitations |
imposed by various countries
|
| gptkbp:healthcare_preparedness |
assessed by governments
|
| gptkbp:healthcare_system_impact |
strain on resources
|
| https://www.w3.org/2000/01/rdf-schema#label |
B.1.1.7 variant
|
| gptkbp:impact |
significant on global pandemic response
|
| gptkbp:impact_on_public_health_policy |
influenced lockdown measures
|
| gptkbp:is_monitored_by |
whole genome sequencing
essential for controlling spread ongoing genomic surveillance |
| gptkbp:is_recognized_as |
September 2020
|
| gptkbp:is_vulnerable_to |
gptkb:Pfizer-Bio_NTech_vaccine
gptkb:Moderna_vaccine gptkb:Astra_Zeneca_vaccine reduced effectiveness against some vaccines |
| gptkbp:model |
B.1.1.7 lineage
|
| gptkbp:mutation_impact |
potential vaccine escape
|
| gptkbp:originated_in |
gptkb:Wuhan_strain
monitored for new mutations |
| gptkbp:provides_guidance_on |
mask-wearing and social distancing recommended
|
| gptkbp:public_awareness |
increased media coverage
|
| gptkbp:public_health_recommendations |
vaccination encouraged
|
| gptkbp:research |
focused on transmissibility
|
| gptkbp:research_focus |
variant characteristics and behavior
|
| gptkbp:responds_to |
adaptation of health strategies
|
| gptkbp:response_to_treatment |
similar to other COVID-19 variants
|
| gptkbp:risk_management |
all age groups
ongoing by health authorities |
| gptkbp:side_effect |
increased hospitalizations
|
| gptkbp:spread_to |
multiple countries
|
| gptkbp:symptoms |
similar to COVID-19 symptoms
|
| gptkbp:track |
tracked by health organizations
critical for outbreak management |
| gptkbp:transmission |
monitored in communities
|
| gptkbp:variant |
studied for public health implications
|
| gptkbp:variant_comparison |
compared to other variants
|
| gptkbp:variant_containment |
efforts to limit spread
|
| gptkbp:variant_control_measures |
implemented by governments
|
| gptkbp:variant_epidemiology |
studied for patterns of spread
|
| gptkbp:variant_global_response |
coordinated by health organizations.
|
| gptkbp:variant_health_guidelines |
updated based on new data
|
| gptkbp:variant_healthcare_guidance |
provided to medical professionals
|
| gptkbp:variant_impact_assessment |
conducted by health agencies
|
| gptkbp:variant_impact_on_society |
significant during pandemic waves
|
| gptkbp:variant_public_awareness_campaigns |
launched to inform the public
|
| gptkbp:variant_public_health_response |
adapted to new findings
|
| gptkbp:variant_research |
ongoing to understand behavior
|
| gptkbp:who_designation |
Variant of Concern
|
| gptkbp:bfsParent |
gptkb:N501_Y
|
| gptkbp:bfsLayer |
6
|